The Spectator

UK Drugs Policy Commission responds to Melanie Phillips

Melanie Phillips makes three allegations about the UK Drug Policy Commission in her 22 May Spectator Blog, “Britain’s Drug Wars”.

First is that we are a “bunch of self appointed busybodies of no status or authority whatsoever”. As a charity we may be self-appointed but a quick look at our web-site would have shown that our Commissioners are people of significant stature and reputation in their respective fields.

Second is that we are “intent on bringing about the legalisation of drugs”. This is an absolute travesty and a wilful misrepresentation of our work which is aimed at supporting a more informed public and political debate about addressing issues of drug policy and practice in the UK through the use of sound evidence. An examination of our recently published evidence review “Reducing Drug Use & Reducing Reoffending” would have shown any rookie journalist that the Commission could in no way be accused of being closet “legalisers”. Its first conclusion was that the principle of using criminal justice system-based interventions to encourage engagement with treatment is supported by the international and much domestic evidence.

Finally she asks why the UKDPC research is “not being opened up to public scrutiny like other research?”. There is no secret or conspiracy in the work we are doing-it is all publicly accessible through our web site (including our submission to the ACMD about cannabis reclassification). We are currently working on four major pieces of work: shortly we will be publishing a review of the international evidence for the effectiveness of efforts to tackle drug markets and distribution networks in the UK.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.


Unlock more articles



Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in